Literature DB >> 18261174

Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates.

I W Gibson1, W Gwinner, V Bröcker, B Sis, J Riopel, I S D Roberts, I Scheffner, G S Jhangri, M Mengel.   

Abstract

While glomerulitis is graded according to the Banff classification, no criteria for scoring peritubular capillaritis (PTC) have been established. We retrospectively applied PTC-scoring criteria to 688 renal allograft (46 preimplantation, 461 protocol, 181 indication) biopsies. A total of 26.3% of all analyzed biopsies had peritubular capillaritis (implant 0%, protocol 17.6%, indication 45.5%; p < 0.0001). The most common capillaritis pattern was of moderate severity (5-10 luminal cells), focal in extent (10-50% of PTC), with a minority of neutrophils. A total of 24% of C4d- compared with 75% of C4d+ biopsies showed capillaritis (p < 0.0001). More than 80% of biopsies with glomerulitis had peritubular capillaritis. A total of 50.4% of biopsies with borderline or T-cell mediated rejection (TCMR) and 14.1% of biopsies without TCMR or antibody-mediated rejection (ABMR) showed capillaritis (p < 0.0001). The inter-observer reproducibility of the PTC-scoring features was fair to moderate. Diffuse capillaritis detected in early protocol biopsies had significant negative prognostic impact in terms of glomerular filtration rate 2 years posttransplantation. Indication biopsies show a significantly higher prevalence of capillaritis than protocol biopsies (45.5% vs. 17.6%; p < 0.0001). Capillaritis is more frequent and pronounced in ABMR, but can be observed in TCMR cases. Thus, scoring of peritubular capillaritis is feasible and can provide prognostic and diagnostic information in renal allograft biopsies.

Mesh:

Substances:

Year:  2008        PMID: 18261174     DOI: 10.1111/j.1600-6143.2007.02137.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.

Authors:  E K Page; A J Page; J Kwun; A C Gibby; F Leopardi; J B Jenkins; E A Strobert; M Song; R A Hennigar; N Iwakoshi; S J Knechtle
Journal:  Am J Transplant       Date:  2012-07-09       Impact factor: 8.086

2.  Peritubular capillaritis in the renal allograft takes center stage.

Authors:  Lorraine C Racusen; Serena M Bagnasco
Journal:  Kidney Int       Date:  2015-08       Impact factor: 10.612

3.  Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates.

Authors:  Marco Delsante; Umberto Maggiore; Jonathan Levi; David E Kleiner; Annette M Jackson; Lois J Arend; Stephen M Hewitt; Naima Carter-Monroe; Serena M Bagnasco; Avi Z Rosenberg
Journal:  Transpl Int       Date:  2018-12-11       Impact factor: 3.782

4.  The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.

Authors:  Nicolas Kozakowski; Harald Herkner; Georg A Böhmig; Heinz Regele; Christoph Kornauth; Gregor Bond; Željko Kikić
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

5.  A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.

Authors:  Weijia Zhang; Zhengzi Yi; Karen L Keung; Huimin Shang; Chengguo Wei; Paolo Cravedi; Zeguo Sun; Caixia Xi; Christopher Woytovich; Samira Farouk; Weiqing Huang; Khadija Banu; Lorenzo Gallon; Ciara N Magee; Nader Najafian; Milagros Samaniego; Arjang Djamali; Stephen I Alexander; Ivy A Rosales; Rex Neal Smith; Jenny Xiang; Evelyne Lerut; Dirk Kuypers; Maarten Naesens; Philip J O'Connell; Robert Colvin; Madhav C Menon; Barbara Murphy
Journal:  J Am Soc Nephrol       Date:  2019-07-05       Impact factor: 10.121

Review 6.  Current pathological perspectives on chronic rejection in renal allografts.

Authors:  Shigeo Hara
Journal:  Clin Exp Nephrol       Date:  2016-11-16       Impact factor: 2.801

Review 7.  Biomarkers for kidney transplant rejection.

Authors:  Denise J Lo; Bruce Kaplan; Allan D Kirk
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

8.  Chronic progressive calcineurin nephrotoxicity: an overstated concept.

Authors:  Arthur J Matas
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

9.  Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited.

Authors:  George Liapis; Harsharan K Singh; Vimal K Derebail; Adil M H Gasim; Tomasz Kozlowski; Volker Nickeleit
Journal:  Transplantation       Date:  2012-09-27       Impact factor: 4.939

10.  Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Authors:  R Neal Smith; Fahim Malik; Nelson Goes; Alton B Farris; Emmanuel Zorn; Susan Saidman; Nina Tolkoff-Rubin; Sonika Puri; Waichi Wong
Journal:  Transpl Immunol       Date:  2012-08-30       Impact factor: 1.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.